Literature DB >> 10515661

Does pH 6 beta-galactosidase activity indicate cell senescence?

D R Krishna1, B Sperker, P Fritz, U Klotz.   

Abstract

Apparently two forms of beta-galactosidase (beta-GAL) in cells or tissue sections can be detected by enzyme histochemical staining (X-GAL). Using a sensitive and specific HPLC method we have determined the pH dependent activity of beta-GAL in cell lines of lung carcinoma (A549), colon carcinoma (Caco2-TC7), promyelocytic leukemia (HL60), hepatoma (HepG2) and human liver homogenates. The HPLC method has been validated and the influence of pH and substrate concentration was studied. There was a good linear correlation between HPLC and quantitative enzyme histochemistry (pH 4.5: r = 0.985; pH 6.0: r = 0.967). Both, pH 4.5 beta-GAL and pH 6 beta-GAL could be demonstrated in all biological material tested and pH 6 beta-GAL activity was always lower (25-50%) than pH 4.5 activity. In Caco2-TC7 cells both activities increased by a factor of 10 from day 3 to day 17 after seeding. In addition, since the beta-GAL activity decreased with increase in pH both in human liver homogenates (independent of the age of the donor) as well as in tumor cell lysates in a similar fashion we believe that the activity at pH 6 can hardly be considered as an exclusive 'senescence marker'. In addition, the more sensitive HPLC method could demonstrate activity in cells that showed negative reaction with X-GAL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515661     DOI: 10.1016/s0047-6374(99)00031-7

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  12 in total

Review 1.  A comparative analysis of the cell biology of senescence and aging.

Authors:  Eun Seong Hwang; Gyesoon Yoon; Hyun Tae Kang
Journal:  Cell Mol Life Sci       Date:  2009-05-07       Impact factor: 9.261

2.  Status of mTOR activity may phenotypically differentiate senescence and quiescence.

Authors:  Sohee Cho; Eun Seong Hwang
Journal:  Mol Cells       Date:  2012-05-07       Impact factor: 5.034

3.  α-Fucosidase as a novel convenient biomarker for cellular senescence.

Authors:  Dominic G Hildebrand; Simon Lehle; Andreas Borst; Sebastian Haferkamp; Frank Essmann; Klaus Schulze-Osthoff
Journal:  Cell Cycle       Date:  2013-05-13       Impact factor: 4.534

4.  Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle.

Authors:  Coralie Cazin; Aurelie Chiche; Han Li
Journal:  J Vis Exp       Date:  2017-10-26       Impact factor: 1.355

5.  Subcellular distribution and activity of mechanistic target of rapamycin in aged retinal pigment epithelium.

Authors:  Bo Yu; Pei Xu; Zhenyang Zhao; Jiyang Cai; Paul Sternberg; Yan Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

6.  Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.

Authors:  Olga V Leontieva; Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

7.  Quantitative digital in situ senescence-associated β-galactosidase assay.

Authors:  Liran I Shlush; Shalev Itzkovitz; Ariel Cohen; Aviad Rutenberg; Ron Berkovitz; Shiran Yehezkel; Hofit Shahar; Sara Selig; Karl Skorecki
Journal:  BMC Cell Biol       Date:  2011-04-15       Impact factor: 4.241

8.  Gamma-tocotrienol modulation of senescence-associated gene expression prevents cellular aging in human diploid fibroblasts.

Authors:  Suzana Makpol; Azalina Zainuddin; Kien Hui Chua; Yasmin Anum Mohd Yusof; Wan Zurinah Wan Ngah
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

9.  Gerosuppression in confluent cells.

Authors:  Olga V Leontieva; Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2014-12       Impact factor: 5.682

10.  Possible role of α-mannosidase and β-galactosidase in larynx cancer.

Authors:  Ewa Olszewska; Malgorzata Borzym-Kluczyk; Ireneusz Rzewnicki; Jerzy Wojtowicz; Marek Rogowski; Jan Krzysztof Pietruski; Aneta Czajkowska; Andrzej Sieskiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.